Palforzia Initial Dose Escalation Kit (4 - 17 years)
RxNorm 2279419

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 2279419 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Palforzia Initial Dose Escalation Kit (4 - 17 years).

The following semantic concepts and normalized strings are associated with this clinical entity:

PSN
Palforzia Initial Dose Escalation Kit (4 - 17 years)
AUI:12953434
View
SY
Palforzia Initial Dose Escalation Kit (4 - 17 years)
AUI:12953433
View
BPCK
{2 (peanut (Arachis hypogaea) allergen-dnfp 0.5 mg Oral Powder [Palforzia]) / 11 (peanut (Arachis hypogaea) allergen-dnfp 1 mg Oral Powder [Palforzia]) } Pack [Palforzia Initial Dose Escalation]
AUI:11828014
View

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

PSNPrescribable

Prescribable Name (PSN):
Palforzia Initial Dose Escalation Kit (4 - 17 years)
(Atom ID: 12953434)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
Palforzia Initial Dose Escalation Kit (4 - 17 years)
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2279419
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12953434
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
PSN
Prescribable Name (Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.)
Source Code
2279419
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.
SYPrescribable

Synonym (SY):
Palforzia Initial Dose Escalation Kit (4 - 17 years)
(Atom ID: 12953433)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
Palforzia Initial Dose Escalation Kit (4 - 17 years)
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2279419
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12953433
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SY
Synonym (Synonym of another TTY, given for clarity.)
Source Code
2279419
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.
BPCKPrescribable

Brand Name Pack (BPCK):
{2 (peanut (Arachis hypogaea) allergen-dnfp 0.5 mg Oral Powder [Palforzia]) / 11 (peanut (Arachis hypogaea) allergen-dnfp 1 mg Oral Powder [Palforzia]) } Pack [Palforzia Initial Dose Escalation]
(Atom ID: 11828014)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
{2 (peanut (Arachis hypogaea) allergen-dnfp 0.5 MG Oral Powder [Palforzia]) / 11 (peanut (Arachis hypogaea) allergen-dnfp 1 MG Oral Powder [Palforzia]) } Pack [Palforzia Initial Dose Escalation]
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2279419
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
11828014
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
BPCK
Brand Name Pack ({# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name])
Source Code
2279419
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Technical Attributes & Logic

RXN HUMAN DRUG
US
Drug available for use in Humans